On 9 February 2016, the European Parliament and Council published the amended version of the Falsified Medicines Directive (FMD), detailing the characteristics of the security features that will be required on packaging for medicinal products for human use. It stated that both a unique identifier and an anti-tampering device will be mandatory, helping to address the current ever-growing threat of counterfeit medicines. Ian Lemon at Essentra reviews global counterfeiting.